BPC-157, a stable gastric pentadecapeptide, demonstrates broader systemic healing effects across multiple tissue types including tendons, muscles, and the gastrointestinal tract through angiogenic and growth factor pathways
Cagrilintide (AM833) Cagrilintide is a long-acting amylin analog designed for once-weekly (OW) SC administration (based on the structure of natural amylin), developed by Novo Nordisk [112]
Its efficacy when topically applied on skin has not been adequately studied
AOD-9604 trials did not demonstrate significant weight loss compared to placebo
Always consult a healthcare professional before starting any supplement
This route carries a higher risk of certain side effects: 5,7,8 Allergic reactions: Hives, swelling, difficulty breathing, or severe skin reactions (e.g., Stevens-Johnson syndrome)